Track topics on Twitter Track topics that are important to you
NEW YORK, Sept. 5, 2017 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe ("WCAS" or the "Firm"), a leading private equity firm focused exclusively on the technology and healthcare industries, announced today that Gregory Lau has joined the Firm as a General Partner and a member of its fundraising and investor relations team. Mr. Lau joins WCAS from FFL Partners, a middle-market private equity firm, where he was Managing Director and head of fundraising and investor relations.
Tony de Nicola, President and Managing Partner of WCAS, said, "We are pleased to welcome Greg to WCAS. We look forward to benefiting from his deep expertise in fundraising and investor relations as we enhance our already strong capabilities in this important area of our Firm and continue to strengthen our relationships with our global Limited Partner base."
Mr. Lau noted, "I have long respected WCAS for its success investing in technology and healthcare over the past four decades. I am excited to join the Firm as we seek to continue to build value for WCAS's Limited Partners."
At FFL Partners, Mr. Lau was head of fundraising and investor relations and led the fundraising of FFL Capital Partners IV, which achieved its $2.0 billion hard cap. He originally joined the firm in 2000 and served in both investing and fundraising roles over the years. Mr. Lau received an A.B. cum laude in mechanical engineering from Harvard College in 1999 and a Master of Business Administration from Harvard Business School in 2006.
About Welsh, Carson, Anderson & Stowe WCAS focuses its investment activity in two target industries: technology and healthcare. Since its founding in 1979, WCAS has organized 16 limited partnerships with total capital of over $22 billion. The Firm is currently investing an equity fund, Welsh, Carson, Anderson and Stowe XII, L.P., which closed on over $3.3 billion in commitments. WCAS has a current portfolio of approximately twenty-five companies with 2016 annual revenues totaling $15 billion. WCAS's strategy is to partner with outstanding management teams and build value for its investors through a combination of operational improvements, internal growth initiatives and strategic acquisitions. See www.wcas.com to learn more.
Contact: Jon Rather, General Partner
View original content:http://www.prnewswire.com/news-releases/welsh-carson-anderson--stowe-names-gregory-lau-as-a-general-partner-and-member-of-the-firms-fundraising-and-investor-relations-team-300513692.html
SOURCE Welsh, Carson, Anderson & StoweNEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.